Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart DiseaseInsights from ENGAGE AF-TIMI 48

被引：1
|
作者：
Owens, Ryan E. [1 ]
Kabra, Rajesh [2 ]
Oliphant, Carrie S. [3 ]
机构：
[1] Univ Oklahoma, Coll Pharm, Dept Pharm Clin & Adm Sci, Oklahoma City, OK 73106 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med, Div Cardiol, Memphis, TN 38163 USA
[3] Univ Tennessee, Coll Pharm, Methodist Univ Hosp, Dept Clin Pharm, Memphis, TN USA
来源：
CLINICAL CARDIOLOGY | 2017年 / 40卷 / 08期
关键词：
Valvular heart disease; Arrhythmia; all; management; WARFARIN;
D O I：
10.1002/clc.22690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Murphy, Sabina A.
    Brown, Karen
    Jarolim, Petr
    Mercuri, Michele
    Antman, Elliott M.
    Morrow, David A.
    JAMA CARDIOLOGY, 2016, 1 (09) : 999 - 1006
  • [32] Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
    Chao, Tze-Fan
    Chen, Shih-Ann
    Ruff, Christian T.
    Hamershock, Rose A.
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1518 - +
  • [33] Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
    Oyama, Kazuma
    Giugliano, Robert P.
    Berg, David D.
    Ruff, Christian T.
    Jarolim, Petr
    Tang, Minao
    Murphy, Sabina A.
    Lanz, Hans J.
    Grosso, Michael A.
    Antman, Elliott M.
    Braunwald, Eugene
    Morrow, David A.
    EUROPEAN HEART JOURNAL, 2021, 42 (17) : 1698 - 1706
  • [34] Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
    Berg, David D.
    Ruff, Christian T.
    Jarolim, Petr
    Giugliano, Robert P.
    Nordio, Francesco
    Lanz, Hans J.
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Morrow, David A.
    CIRCULATION, 2019, 139 (06) : 760 - 771
  • [35] Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)
    Aisenberg, James
    Chatterjee-Murphy, Prapti
    Flack, Kathryn Friedman
    Weitz, Jeffrey I.
    Ruff, Christian T.
    Nordio, Francesco
    Mercuri, Michele F.
    Choi, Youngsook
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (05): : e003998
  • [36] Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial
    Wang, Kaijun
    Li, Haiyan
    Kwong, Winghan J.
    Antman, Elliott M.
    Ruff, Christian T.
    Giugliano, Robert P.
    Cohen, David J.
    Magnuson, Elizabeth A.
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    Rosell, M.
    Cuneo, C.
    Bocanera, M.
    D'Amico, A.
    Cendali, G.
    Dran, R.
    Moreno, V.
    Estol, C.
    Davolos, M.
    Facello, A.
    Facello, M.
    Falu, E.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
  • [37] Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
    Link, Mark S.
    Giugliano, Robert P.
    Ruff, Christian T.
    Scirica, Benjamin M.
    Huikuri, Heikke
    Oto, Ali
    Crompton, Andrea E.
    Murphy, Sabina A.
    Lanz, Hans
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    Rosell, M.
    Cuneo, C.
    Bocanera, M.
    D'Amico, A.
    Cendali, G.
    Dran, R.
    Moreno, V.
    Estol, C.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (01)
  • [38] Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)
    Ruff, Christian T.
    Giugliano, Robert P.
    Antman, Elliott M.
    Crugnale, Sharon E.
    Bocanegra, Tomas
    Mercuri, Michele
    Hanyok, James
    Patel, Indravadan
    Shi, Minggao
    Salazar, Dan
    McCabe, Carolyn H.
    Braunwald, Eugene
    AMERICAN HEART JOURNAL, 2010, 160 (04) : 635 - U266
  • [39] Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review
    Owens, Ryan E.
    Kabra, Rajesh
    Oliphant, Carrie S.
    CLINICAL CARDIOLOGY, 2017, 40 (06) : 407 - 412
  • [40] Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
    Ruff, Christian T.
    Giugliano, Robert P.
    Braunwald, Eugene
    Morrow, David A.
    Murphy, Sabina A.
    Kuder, Julia F.
    Deenadayalu, Naveen
    Jarolim, Petr
    Betcher, Joshua
    Shi, Minggao
    Brown, Karen
    Patel, Indravadan
    Mercuri, Michele
    Antman, Elliott M.
    LANCET, 2015, 385 (9984) : 2288 - 2295
12345